Regular Diabetes Check-Ups: What Tests Do You Actually Need?

Living with diabetes can turn healthcare into a collection of numbers. Blood glucose appears on one report, HbA1c on another. Then come blood pressure, cholesterol and kidney results.

After a while, it is possible to collect numbers without knowing what they are supposed to tell us.

A diabetes check-up should answer a wider question: is diabetes beginning to affect another part of the body before symptoms appear?

That is why monitoring cannot be reduced to a fasting glucose test.

HbA1c looks beyond today’s glucose

A home glucose reading tells us what is happening at that moment. HbA1c reflects average glucose exposure over roughly the previous two to three months.

The American Diabetes Association’s 2026 Standards of Care recommend assessing glycemic status at least twice a year when treatment and glucose levels are stable and goals are being met.

Testing is usually more frequent when treatment has recently changed or glucose goals are not being met. Changes in health and episodes of significant hypoglycemia or hyperglycemia can also justify closer assessment.

For many people in those circumstances, that means an HbA1c about every three months.

The target is not identical for everyone. Age, other illnesses, risk of hypoglycemia and the burden of treatment can affect what an appropriate goal looks like.

Kidney monitoring needs more than creatinine

Diabetes-related kidney disease can develop quietly.

Many laboratory reports already provide an estimated glomerular filtration rate, or eGFR, alongside serum creatinine. It gives useful information about how well the kidneys are filtering blood.

But filtration is only part of the check.

The urine albumin-to-creatinine ratio, usually called UACR, looks for albumin leaking into the urine. That can reveal kidney damage even when a person feels perfectly well.

For people with type 2 diabetes, current ADA kidney guidance recommends checking both UACR and eGFR at least once a year. In type 1 diabetes, annual screening generally begins once diabetes has been present for five years.

Once chronic kidney disease is established, the timetable changes. Depending on its stage and risk of progression, UACR and eGFR may need checking several times during the year.

So when I look at a diabetes report, I would not ask only, “What is my creatinine?”

I would also want to know whether my urine albumin has been checked.

Blood pressure is part of diabetes care

Blood pressure sometimes gets treated as a separate problem. In diabetes, the boundaries are not so neat.

Hypertension adds to cardiovascular risk and can worsen kidney disease. Blood pressure therefore belongs in routine diabetes care.

One unusual reading is not the whole story. Patterns matter. When clinic readings do not seem representative, measurements taken outside the clinic can sometimes add useful information.

The point is to look at cardiovascular and kidney risk alongside glucose rather than treating each result in isolation.

Cholesterol results should lead to a decision

A lipid profile commonly reports LDL cholesterol, HDL cholesterol and triglycerides, along with total cholesterol.

For someone with diabetes, the purpose is not merely to discover whether a number falls inside a laboratory reference range. Lipid results help clinicians assess cardiovascular risk and make treatment decisions.

How often they need repeating depends on circumstances. Starting or changing lipid-lowering treatment can justify earlier reassessment. Stable results on established treatment may follow a different schedule.

This is a useful question to take to an appointment: What decision will this result change?

That question is often more useful than ordering a test simply because it appeared on an annual checklist. For readers who want the older laboratory-focused overview, I have also retained my article on blood tests used in diabetes monitoring.

The eyes may change before vision does

Diabetic retinopathy can develop before a person notices a meaningful change in eyesight.

For people with type 2 diabetes, the ADA recommends an initial dilated and comprehensive eye examination at diagnosis. Adults with type 1 diabetes should generally have the first such examination within five years after diabetes begins.

The schedule can change after that.

If repeated examinations show no retinopathy and glucose indicators remain within the person’s target range, screening every one to two years may sometimes be considered. If retinopathy is present, examinations are generally needed at least annually. Progressive or sight-threatening disease requires closer ophthalmic follow-up.

An appointment for new reading glasses is not automatically a diabetic retinal examination.

Feet can lose their warning system

Pain normally tells us that something is wrong. Diabetic neuropathy can weaken that warning.

A blister or small wound may then receive little attention because it does not hurt much.

A comprehensive foot evaluation should be performed at least annually. It includes the skin and foot structure, neurological assessment and an assessment of circulation.

People who have lost protective sensation, previously developed a foot ulcer or undergone an amputation need closer surveillance. For these higher-risk groups, the ADA recommends foot inspection at every visit.

I have discussed this separately in my recently updated article on diabetic foot warning signs and prevention. The important lesson is simple: lack of pain does not prove that a diabetic foot injury is harmless.

Dental care belongs in the picture

Teeth and gums are easy to forget when thinking about diabetes complications.

They should not be.

Diabetes and periodontal disease have an important relationship, and poor glucose control can make oral-health problems harder to manage.

A dental examination is therefore part of sensible long-term diabetes care. The CDC diabetes care schedule includes dental examination in its annual care guidance, with more frequent visits when clinically recommended.

Medication review can reveal what another blood test cannot

A diabetes appointment should also include the medicines a person is actually taking.

Are they still being taken as prescribed? Has kidney function changed? Are side effects appearing? Has another illness changed the balance between benefit and risk?

Those questions sometimes matter more than adding another test to the laboratory form.

Long-term metformin use is a good example. Metformin can be associated with vitamin B12 deficiency. That does not mean everyone taking metformin needs a B12 test at every visit. It does mean that B12 deserves consideration when clinically appropriate, particularly if anemia or symptoms compatible with neuropathy appear.

I have a separate guide on what long-term metformin users should discuss with their doctor.

Monitoring should follow the patient, not a rigid internet checklist.

What I would ask at my next diabetes review

I would take my previous results with me.

I would want to know when my HbA1c was last measured and whether it is moving in the right direction. I would check whether kidney screening included both eGFR and UACR.

Then I would look beyond the laboratory sheet.

When were my eyes last examined for diabetic changes? Has someone properly examined my feet? Are my blood pressure and lipid results being considered as part of my overall cardiovascular risk? Is there anything about my medicines that now needs reviewing?

Some of these checks may be due now. Others may not be.

That is the point.

Diabetes monitoring is not about ordering every possible test once a year. It is about noticing change early enough to respond to it.

A normal kidney result, a clear retinal examination or an intact foot examination may look uneventful on paper. In long-term diabetes care, uneventful can be very good news.

Medical note: This article provides general health information and does not replace individual medical advice. The appropriate tests and their frequency depend on diabetes type, age, medications, pregnancy, other health conditions, previous results and treatment goals.

Leave a Reply